Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2025 · 42 positions · Total reported value $1.34B · Top-10 concentration 68.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, Cormorant Asset Management, LP disclosed 42 equity positions with a combined reported value of $1.34B. The filing implies a focused portfolio: its ten largest positions account for 68.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were MLTX ($400.92M), EYPT ($78.34M), BBIO ($69.09M). By sector, the heaviest allocations are Health Care 75.7%, Industrials 5.8%. Versus the prior quarter, allocation shifted toward Industrials (+2.1pp) and away from Health Care (-2.4pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 87% of names.

The largest new positions opened in Q2 2025 were VRNA ($33.10M), CABA ($7.60M), VYNE ($2.26M).

Of the 2 positions fully exited versus the prior quarter, the largest were RYTM ($7.95M), OKUR ($7.90M), PLRX ($4.05M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • VRNA VERONA PHARMA PLC · $33.10M
  • CABA CABALETTA BIO INC · $7.60M
  • VYNE YARROW BIOSCIENCES INC · $2.26M

Fully Exited (vs previous quarter)

  • RYTM RHYTHM PHARMACEUTICALS INC · prev qtr: $7.95M
  • OKUR ONKURE THERAPEUTICS INC · prev qtr: $7.90M
  • PLRX PLIANT THERAPEUTICS INC · prev qtr: $4.05M

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 75.7%
Other 18.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.49M $400.92M 29.86%
29.86%
Hold
2 8.32M $78.34M 5.83%
5.83%
Hold
3 1.60M $69.09M 5.15%
5.15%
Reduce
4 1.62M $68.33M 5.09%
5.09%
Reduce
5 1.12M $58.91M 4.39%
4.39%
Add
6 4.25M $55.74M 4.15%
4.15%
Add
7 540.00K $54.35M 4.05%
4.05%
Add
8 800.00K $52.68M 3.92%
3.92%
Reduce
9 2.17M $39.39M 2.93%
2.93%
Add
10 1.50M $34.65M 2.58%
2.58%
Add
11 2.94M $33.44M 2.49%
2.49%
Hold
12 350.00K $33.10M 2.47%
2.47%
New
13 2.91M $30.89M 2.30%
2.30%
Hold
14 1.06M $27.66M 2.06%
2.06%
Hold
15 2.09M $27.42M 2.04%
2.04%
Reduce
16 1.45M $25.60M 1.91%
1.91%
Reduce
17 2.01M $24.50M 1.82%
1.82%
Hold
18 1.10M $19.20M 1.43%
1.43%
Reduce
19 2.38M $16.39M 1.22%
Form 4 · 1 →
1.22%
Hold
20 2.13M $16.29M 1.21%
1.21%
Hold
21 625.00K $16.25M 1.21%
1.21%
Reduce
22 1.00M $14.02M 1.04%
1.04%
Reduce
23 3.38M $13.93M 1.04%
1.04%
Hold
24 300.00K $12.15M 0.91%
0.91%
Reduce
25 400.00K $11.50M 0.86%
0.86%
Reduce
26 400.00K $11.38M 0.85%
0.85%
Hold
27 800.19K $10.82M 0.81%
0.81%
Hold
28 100.00K $10.44M 0.78%
0.78%
Reduce
29 2.14M $8.84M 0.66%
0.66%
Reduce
30 2.32M $8.46M 0.63%
0.63%
Hold
31 700.00K $7.99M 0.59%
0.59%
Hold
32 5.00M $7.60M 0.57%
0.57%
New
33 2.15M $6.44M 0.48%
0.48%
Hold
34 3.57M $6.43M 0.48%
0.48%
Hold
35 465.00K $5.81M 0.43%
0.43%
Add
36 175.00K $5.69M 0.42%
0.42%
Hold
37 200.00K $5.68M 0.42%
0.42%
Reduce
38 200.00K $4.01M 0.30%
0.30%
Reduce
39 254.16K $2.88M 0.21%
0.21%
Hold
40 603.03K $2.87M 0.21%
0.21%
Hold
41 1.37M $2.26M 0.17%
0.17%
New
42 10.00K $141.10K 0.01%
0.01%
Hold

FAQ

What did Cormorant Asset Management, LP buy in 2025-Q2?

In its 2025-Q2 13F filing, Cormorant Asset Management, LP reported 42 equity positions worth $1.34B in aggregate; its largest disclosed positions were MLTX ($400.92M), EYPT ($78.34M), BBIO ($69.09M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $1.34B of long equity holdings across 42 positions as of 2025-Q2. Top-10 holdings account for 68.0% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →